[
  {
    "ts": null,
    "headline": "DexCom Inc. stock underperforms Tuesday when compared to competitors",
    "summary": "DexCom Inc. stock underperforms Tuesday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=6ed778c6bab9fa1062b898e5a9a4891f7ca55b78e5be1ca345ea22a193917cd0",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1740502500,
      "headline": "DexCom Inc. stock underperforms Tuesday when compared to competitors",
      "id": 132891333,
      "image": "",
      "related": "DXCM",
      "source": "MarketWatch",
      "summary": "DexCom Inc. stock underperforms Tuesday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=6ed778c6bab9fa1062b898e5a9a4891f7ca55b78e5be1ca345ea22a193917cd0"
    }
  },
  {
    "ts": null,
    "headline": "Seasoned Biopharmaceutical Industry Executives Teri Lawver and Jerry Durso Appointed to Altimmune Board of Directors",
    "summary": "Ms. Lawver, former Chief Commercial Officer of Dexcom and Global Vice President at Johnson & Johnson responsible for billion-dollar Immunology and Cardiovascular & Metabolism Portfolios over her 20-year career Mr. Durso led biopharmaceutical company focused on liver disease as former CEO of Intercept Pharmaceuticals, previously oversaw multiple blockbuster franchises including cardiovascular and diabetes during 22-year tenure at Sanofi GAITHERSBURG, Md., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Altimmu",
    "url": "https://finnhub.io/api/news?id=2abf94dd80f8a693ed77e04ff1a8646ddeda72fbbad8337fb59f7c7907a6889d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1740486600,
      "headline": "Seasoned Biopharmaceutical Industry Executives Teri Lawver and Jerry Durso Appointed to Altimmune Board of Directors",
      "id": 133190182,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DXCM",
      "source": "Yahoo",
      "summary": "Ms. Lawver, former Chief Commercial Officer of Dexcom and Global Vice President at Johnson & Johnson responsible for billion-dollar Immunology and Cardiovascular & Metabolism Portfolios over her 20-year career Mr. Durso led biopharmaceutical company focused on liver disease as former CEO of Intercept Pharmaceuticals, previously oversaw multiple blockbuster franchises including cardiovascular and diabetes during 22-year tenure at Sanofi GAITHERSBURG, Md., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Altimmu",
      "url": "https://finnhub.io/api/news?id=2abf94dd80f8a693ed77e04ff1a8646ddeda72fbbad8337fb59f7c7907a6889d"
    }
  }
]